This submission is a new application for the UCLA IDDRC, entitled UCLA Center for Translational Research in Neurodevelopment (UC-TRaN). The fundamental purpose of our Center is to provide an optimal environment for performing outstanding research into the causes, mechanisms, and treatments of intellectual and developmental disorders. The new leadership model in the center emphasizes collaborations among Center investigators, core personnel, and community partners, with support for research spanning basic research and clinical practice.
Our aims are 1) to create cutting edge and cost effective infrastructure resources in facilities and personnel for IDD investigators; 2) to provide integrated services within cores that support research from multidisciplinary teams and multiple levels of analysis; 3) to promote interactions between cores and among research investigators to promote collaborative, multidisciplinary and translational research, and 4) to create educational and outreach opportunities within the center, in collaboration with a West Coast Consortium of IDDRCs and community partners. We propose five interacting cores: 1) Administration, Education and Outreach; 2) Genetics, Genomics and BioInformatics, which performs genetic analysis, sequencing, expression, and provides Big Data resources; 3) Cells, Circuits and Systems analysis, supporting electrophysiology, human iPSC and cerebral organoid culture development, and optogenetics; 4) Structural and Functional Visualization, which provides access to and analysis of imaging tools from miniaturized microscopes through animal and human MRI; and 5) Clinical Translation, supporting clinical trial development, recruitment, phenotyping across species, and collecting biosamples. The Center proposes an exciting model research project, Neurophysiological biomarkers of cognition in Dup15 syndrome: From mouse models to patients. Dup15q11.2-13.1 is associated with marked cognitive impairment and other symptoms of developmental delay. The study examines a novel EEG biomarker in a cohort of children with Dup15q and in two separate mouse models of Dup15q syndrome, one defined by an overexpression of a single gene, UBE3A, and the other from a full duplication of the region. In the animal model the project will test three mechanism-based pharmacologic treatments: d-serine, rapamycin, and a GABA-A ?5 receptor subunit inverse agonist, to determine whether these treatments change cell activation patterns and behavior. Together, the project and cores support our primary goal of optimizing outcomes of individuals with intellectual and developmental disabilities by promoting outstanding translational research.

Public Health Relevance

This is a new application for the UCLA IDDRC, the UCLA Center for Translational Research in Neurodevelopment (UC-TRaN). The Center is dedicated to improving the lives of individuals with intellectual and developmental disabilities by creating a research environment optimized for studying the basic cases and mechanisms leading to IDDs, and designing effective treatments and prevention strategies. Our center is strongly focused on building collaborations among researchers studying the same problems with different techniques, and partnering with the community to ensure scientific discoveries will benefit individuals. Our application builds on over 50 years of dedicated research into intellectual and developmental disorders.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD087101-03
Application #
9389334
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Parisi, Melissa
Project Start
2015-11-01
Project End
2020-05-31
Budget Start
2017-11-01
Budget End
2018-10-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Dickinson, Abigail; DiStefano, Charlotte; Lin, Yin-Ying et al. (2018) Interhemispheric alpha-band hypoconnectivity in children with autism spectrum disorder. Behav Brain Res 348:227-234
Nachun, Daniel; Gao, Fuying; Isaacs, Charles et al. (2018) Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich's ataxia patients. Hum Mol Genet 27:2965-2977
Meyer, Jochen F; Golshani, Peyman; Smirnakis, Stelios M (2018) The Effect of Single Pyramidal Neuron Firing Within Layer 2/3 and Layer 4 in Mouse V1. Front Neural Circuits 12:29
Dickinson, Abigail; DiStefano, Charlotte; Senturk, Damla et al. (2018) Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci 47:643-651
Rao, Jia-Sheng; Zhao, Can; Zhang, Aifeng et al. (2018) NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. Proc Natl Acad Sci U S A 115:E5595-E5604
Douglas, P K; Gutman, Boris; Anderson, Ariana et al. (2018) Hemispheric brain asymmetry differences in youths with attention-deficit/hyperactivity disorder. Neuroimage Clin 18:744-752
Lee, Frank Y; Wang, Huei-Bin; Hitchcock, Olivia N et al. (2018) Sleep/Wake Disruption in a Mouse Model of BLOC-1 Deficiency. Front Neurosci 12:759
Somerville, Leah H; Bookheimer, Susan Y; Buckner, Randy L et al. (2018) The Lifespan Human Connectome Project in Development: A large-scale study of brain connectivity development in 5-21 year olds. Neuroimage 183:456-468
Green, Shulamite A; Hernandez, Leanna M; Bowman, Hilary C et al. (2018) Sensory over-responsivity and social cognition in ASD: Effects of aversive sensory stimuli and attentional modulation on neural responses to social cues. Dev Cogn Neurosci 29:127-139
Clark, Duncan B; Fisher, Celia B; Bookheimer, Susan et al. (2018) Biomedical ethics and clinical oversight in multisite observational neuroimaging studies with children and adolescents: The ABCD experience. Dev Cogn Neurosci 32:143-154

Showing the most recent 10 out of 40 publications